A Look At NeoGenomics (NEO) Valuation After Recent Share Price Momentum Shift [Yahoo! Finance]
NeoGenomics, Inc. (NEO)
Last neogenomics, inc. earnings: 4/28 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.neogenomics.com
Company Research
Source: Yahoo! Finance
in cancer-focused diagnostics invite closer scrutiny from anyone tracking specialized healthcare stocks. See our latest analysis for NeoGenomics. The recent move to a US$12.08 share price comes after a 31.73% 90 day share price return, contrasting with a 34.20% decline in the 1 year total shareholder return. This suggests near term momentum has improved, while longer term holders are still under water. If NeoGenomics has you reassessing cancer testing and diagnostics, this could be a good moment to scan the wider opportunity set across healthcare stocks So with NeoGenomics posting 8.70% annual revenue growth alongside a US$113.47 million net loss and a share price of US$12.08 that sits below the average analyst target, is there a genuine opportunity here, or is the market already pricing in future growth? With NeoGenomics last closing at US$12.08 and the most followed narrative pointing to fair value of about US$13.44, the valuation debate is centered on whether future growt
Show less
Read more
Impact Snapshot
Event Time:
NEO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NEO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NEO alerts
High impacting NeoGenomics, Inc. news events
Weekly update
A roundup of the hottest topics
NEO
News
- NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.MarketBeat
- NeoGenomics sees Q4 revenue of about $190M [Seeking Alpha]Seeking Alpha
- NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue [Yahoo! Finance]Yahoo! Finance
- NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 RevenueBusiness Wire
- NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Cowen Inc.MarketBeat
NEO
Earnings
- 10/28/25 - Beat
NEO
Sec Filings
- 1/12/26 - Form 8-K
- 1/5/26 - Form 4
- 1/5/26 - Form 3
- NEO's page on the SEC website